愛爾眼科醫院集團
?愛爾眼科醫院集團是中國規模的眼科醫療連鎖機構，IPO上市醫療機構（股票代碼: 300015，2015年入選滬深300指數股）。截至2017年7月，已在全國30個省市區建立180余家專業眼科醫院，覆蓋全國醫保人口超過70%，年門診量超過400 萬人。并且，在香港、美國和歐洲也開設有眼科分支機構。
Aier Eye Hospital Group is China's leading hospital network in eye care, and is also China's first IPO listed medical institution (stock code: 300015, one of the CSI 300 index selected in 2015). As of July 2017, Aier Eye Hospital Group has established more than 180 specialized eye hospitals covering 30 provinces and extended our services to 70% of insured population all over the country with over 4 million outpatient visits annually. Recently, we have successfully established our presence in Hongkong,US and Europe.
愛爾眼科致力于引進和吸收國際同步的眼科技術與醫療管理理念，以專業化、規?；?、科學化為發展戰略，推動中國眼科醫療事業的發展。
Aier is committed to the parallel introduction and absorption of world-leading ophthalmic technology and management concept, with professionalism, scale and science as its strategy to advance the development of China's ophthalmic medical care.
通過不斷的探索與實踐，并充分吸納國際的醫療管理經驗的基礎上，成功探索出一套適應中國國情和市場環境的眼科醫院連鎖經營管理模式——“分級連鎖”。利用人才、技術和管理等方面的優勢，通過全國各連鎖醫院良好的診療質量、的醫療服務和專業的市場推廣，使愛爾眼科成為全國各地眼科患者信賴的眼科醫院。
Base on constant exploration and practice, also with absorb advanced international medical management experience, Aier Eye Hospital Group has successfully established the "hierarchical chain" management model that adapts to China's market environment. Utilizing our advantages in talent, technology and management, we aim to provide the most trusted eye care to patients all over the country.
2013年，愛爾眼科醫院集團與中南大學聯合成立專業的眼科醫學院——中南大學愛爾眼科學院，主要培養眼科碩、博士高級醫療人才；2014年，再度與湖北科技大學聯合成立愛爾眼視光學院。2011年和2015年，愛爾眼科先后成立“愛爾眼視光研究所”和“愛爾眼科研究所”。至此，愛爾眼科打通了眼科的醫、學、研三大領域，學院和研究所的成立將使愛爾眼科的科研及臨床水平得到顯著提升，并以此推動中國眼科醫療事業的發展和進步。
In 2013, Aier and Central South University jointly set up Aier School of ophthalmology, CSU, to educate and train medical professionals with advanced degrees; Once again in 2014, Aier joined the Hubei University of Science and Technology to establish the Aier School of Ophthalmology & Optometry. In 2011 and 2015, Aier established the Aier Institute of Optometry and Aier Institute of Ophthalmology respectively. At this point, Aier has bridged all three areas of medicine, education and research, the establishment of these educational and research institutions will significantly boost our research and clinical standards.
截止2016年，愛爾眼科所屬的專業眼科專家和醫生團隊達到近3000名，包括一大批碩士生導師、博士生導師、博士、博士后、留學歐美的學者以及臨床經驗豐富的核心專家，是中國眼科領域備受矚目的有生力量。
As of 2016, Aier has recruited and trained over 3000 doctors and specialized experts, many of whom have studied in elite institutions in Europe and the US. They are China’s driving force in ophthalmology.
2014年7月9日，世界銀行行長金墉參觀考察愛爾眼科長沙醫院，并在全球發展中愛爾眼科的可持續公益慈善模式。2015年，愛爾眼科收購香港亞洲醫療集團，開啟愛爾眼科國際化步伐，2017年，愛爾眼科收購美國知名眼科中心，國際化步伐再下一城。
On July 9,2014, the President of the World Bank Jim Yong Kim visited Changsha Aier Eye Hospital and promoted Aier’s unique sustainable philanthropic model in developing countries. In 2015, Aier acquired Hong Kong Asia Medical Group and paved the way for Aier’s internationalization. In early 2017, Aier acquired a renowned eyecare center in American, which brought Aier’s international expansion to a new stage.
愛爾眼科的發展壯大，始終以“使所有人，無論貧窮富裕，都享有眼健康的權利”為使命，追求社會責任和自身發展的和諧統一，通過性的“交叉補貼”模式，一方面為患者提供更高品質的眼科醫療服務，同時全面開展防盲治盲工作、投身社會公益和幫助弱勢群體，并聯合社會各界，推動整個中國防盲事業的全面發展。
Since its founding, Aier always committed to the mission, “Everyone in everywhere, we do care?“. With its "cross subsidy" model, Aier provides patients with higher quality services, in the meantime dedicate itself to the social welfare and helping vulnerable groups to promote the cause of fighting blindness.
隨著中國醫療衛生體制改革的進一步推進，愛爾眼科順應國家醫療衛生政策和發展趨勢，于2014年在醫療行業推出“合伙人計劃”，致力于改變眼科醫生執業的生態環境，限度地激發核心骨干的力和能動性。愛爾眼科專注于眼科醫療服務事業，預計到 2017年，興建200家具有競爭力的專業連鎖眼科醫院，為更多的人提供高質量、多層次的眼科醫療服務。
In 2014, Aier launched the "Partnership Program" in the healthcare industry to focus on changing the ecological environment for ophthalmologists and maximizing the creativity and initiative of core members. It is expected that by the end of 2017, Aier will have 200 eye hospitals which provide high quality and multi-level eye care to more people.